Learn when to pursue a National Coverage Determination (NCD) and what CMS’s renal denervation decision means for MedTech reimbursement and evidence strategy.
FDA approval doesn’t guarantee insurance payment. Learn why payers reject FDA-cleared devices—and how startups can align early with reimbursement strategies.
Discover why payer dossiers are critical for MedTech startups, even in early stages. Learn how they guide evidence development, coding, and reimbursement strategy.
Discover a five-step Medicaid engagement checklist for MedTech startups. Learn how to map state opportunities, align evidence, and build payer relationships for better coverage success.